BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 174488)

  • 1. Inhibition of vesicular stomatitis virus replication by poly(2'-fluoro-2'-deoxyuridylic acid).
    Grosch JC; Erickson RJ
    Antimicrob Agents Chemother; 1975 Nov; 8(5):544-50. PubMed ID: 174488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of oncornavirus functions by 2'-azido polynucleotides.
    De Clercq E; Billiau A; Hobbs J; Torrence PF; Witkop B
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):284-8. PubMed ID: 47174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of a vesicular stomatitis virus mutant by rifampin.
    Moreau MC
    J Virol; 1974 Sep; 14(3):517-21. PubMed ID: 4368821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral effect of cyclopentenone prostaglandins on vesicular stomatitis virus replication.
    Parker J; Ahrens PB; Ankel H
    Antiviral Res; 1995 Jan; 26(1):83-96. PubMed ID: 7537950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribonucleic acid polymerase induced in L-cells infected with vesicular stomatitis virus.
    Galet H; Shedlarski JG; Prevec L
    Can J Biochem; 1973 May; 51(5):721-9. PubMed ID: 4350448
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand viruses.
    Connor JH; McKenzie MO; Parks GD; Lyles DS
    Virology; 2007 May; 362(1):109-19. PubMed ID: 17258257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the antiviral activity of protein kinase inhibitors against the replication of vesicular stomatitis virus.
    Kim YS; Sagara J; Kawai A
    Biol Pharm Bull; 1995 Jun; 18(6):895-9. PubMed ID: 7550128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-type-specific growth restriction of vesicular stomatitis virus polR mutants is linked to defective viral polymerase function.
    Ostertag D; Hoblitzell-Ostertag TM; Perrault J
    J Virol; 2007 Jan; 81(2):492-502. PubMed ID: 17065214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of three complementation groups of vesicular stomatitis virus.
    Wong PK; Holloway AF; Cormack DV
    Virology; 1972 Dec; 50(3):829-40. PubMed ID: 4118320
    [No Abstract]   [Full Text] [Related]  

  • 10. Homologous viral interference: induction by RNA from defective particles of vesicular stomatitis virus.
    Sreevalsan T
    Science; 1970 Sep; 169(3949):991-3. PubMed ID: 4317405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the virion-associated RNA polymerase of vesicular stomatitis virus by melittin.
    Roy J; Chanda PK; Thornton GB; Luk D; Banerjee AK
    Biochem Biophys Res Commun; 1982 Apr; 105(4):1265-71. PubMed ID: 6285902
    [No Abstract]   [Full Text] [Related]  

  • 12. Production of vesicular stomatitis virus with low infectivity by interferon-treated cells.
    Maheshwari RK; Friedman RM
    J Gen Virol; 1979 Jul; 44(1):261-4. PubMed ID: 227998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA polymerase activity and poly(A) synthesizing activity in defective T particles of vesicular stomatitis virus.
    Reichmann ME; Villarreal LP; Kohne D; Lesnaw J; Holland JJ
    Virology; 1974 Mar; 58(1):240-9. PubMed ID: 4362548
    [No Abstract]   [Full Text] [Related]  

  • 14. Ribonucleic acid synthesis of vesicular stomatitis virus, II. An RNA polymerase in the virion.
    Baltimore D; Huang AS; Stampfer M
    Proc Natl Acad Sci U S A; 1970 Jun; 66(2):572-6. PubMed ID: 4317920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sulfhydryl reagents on the infectivity of vesicular stomatitis virus.
    Beatrice ST; Wagner RR
    Virology; 1980 Jan; 100(2):246-51. PubMed ID: 6243427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA synthesis by vesicular stomatitis virus and a small plaque mutant: effects of cycloheximide.
    Wertz GW; Levine M
    J Virol; 1973 Aug; 12(2):253-64. PubMed ID: 4355930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of vesicular stomatitis virus by kethoxal bis (thiosemicarbazone).
    Levinson W; Oppermann H; Jackson J
    J Gen Virol; 1977 Oct; 37(1):183-90. PubMed ID: 72131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a new region in the vesicular stomatitis virus L polymerase protein which is essential for mRNA cap methylation.
    Grdzelishvili VZ; Smallwood S; Tower D; Hall RL; Hunt DM; Moyer SA
    Virology; 2006 Jul; 350(2):394-405. PubMed ID: 16537083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of transcriptase activity or transcription-inhibiting ability in defective interfering particles of vesicular stomatitis virus.
    Perrault J; Holland JJ
    Virology; 1972 Oct; 50(1):150-70. PubMed ID: 4343109
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiviral effect of a synthetic brassinosteroid on the replication of vesicular stomatitis virus in Vero cells.
    Romanutti C; Castilla V; Coto CE; Wachsman MB
    Int J Antimicrob Agents; 2007 Mar; 29(3):311-6. PubMed ID: 17275263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.